CYP cynata therapeutics limited

He also refused to elaborate, and actually avoided the question...

  1. 4,863 Posts.
    lightbulb Created with Sketch. 344
    He also refused to elaborate, and actually avoided the question about competition, but lauded the safety of MSC technology.

    We already know that, from the Companies that have done testing on naturally derived MSC's, and are near to approval.

    What KK failed to discuss was the "ugly" term, reproducing artificial cells, or reproducing cells artificially for the greenies.

    The question remains the same about manufactured cells in vitro attempted replication.

    It is simply many years away to prove that science when the FDA are just getting their head around the benefits of naturally derived cell technology, or should I say the worlds demand for it already.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
16.0¢ 16.5¢ 16.0¢ $10.82K 65.84K

Buyers (Bids)

No. Vol. Price($)
2 4450 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 88474 2
View Market Depth
Last trade - 15.32pm 20/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.